Purchase 4-FMA, 2-FMA
Discount program, second order - 5% OFF, third order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 4-FMA, 2-FMA for sale
4-Fluoromethamphetamine (4-FMA) (also known as 4-fluoromethylphenidate, para-fluoroamphetamine or 4-FMP) is a stimulant drug related to methamphetamine and 4-fluoroamphetamine. 2-Fluoromethamphetamine (2-FMA) is a stimulant drug of the amphetamine family which has been used as a designer drug.
2-Fluoromethamphetamine (2-FMA) is a stimulant drug related to methamphetamine and 4-fluoroamphetamine. 4-Fluoromethamphetamine (4-FMA) is a stimulant drug of the amphetamine family which has been used as a designer drug.
4-Fluoromethamphetamine (4-FMA) (also known as 4-fluoromethylphenidate, para-fluoroamphetamine or 4-FMP) is a stimulant drug related to methamphetamine and 4-fluoroamphetamine.
4-Fluoromethamphetamine (4-FMA), commonly known as 4-FMP, is a synthetic stimulant substance of the amphetamine family.
The 4-Fluoromethamphetamine is a stimulant drug that belongs to the amphetamine family.
4-FMA is a stimulant drug of the amphetamine family. It has been reported to be sold as a designer drug, but little is known about its pharmacology or toxicology. 2-fluoromethamphetamine (2-FMA) is also a stimulant drug of the amphetamine family and has been used as a designer drug.
4-Fluoro-methamphetamine, commonly known as 4-FMA, is a designer drug of the amphetamine family. Its pharmacology and toxicology are unknown. 2-fluoromethamphetamine (2-FMA) is also a designer drug, which has been sold as such, but it is not well known in the United States.
4-fluoro-N-methyl amphetamine is a designer drug that has been reported to be sold as such, but little is known about its pharmacology or toxicology.
4-FMA is a stimulant sold as a designer drug, but little is known about its toxicology.
4-FMA and 2-fluoromethamphetamine (2-FMA) are stimulants of the amphetamine family.
4-FMA is a stimulant drug of the amphetamine family. Little is known about its pharmacology or toxicology.
2-FMA is widely compared to Lisdexamfetamine (Vyvanse) and dextroamphetamine due to its efficacy as a study or productivity aid. From anecdotal reports, 2-FMA is purported to produce mostly stimulant effects, with some users reporting less euphoria than similar amphetamines.
4-Fluoromethamphetamine (4-FMA) is a stimulant drug related to methamphetamine and 4-fluoroamphetamine.
2-Fluoromethamphetamine (2-FMA) is a novel stimulant of the amphetamine group whose structural and pharmacological properties are closely related to dextroamphetamine but different from lisdexamfetamine. The behavioral and subjective effects of 2-fluoromethamphetamine were compared with those of other stimulants in drug discrimination studies in rats trained to discriminate saline or d-amphetamine. These experiments showed that 2-fluoromethamphetamine had low efficacy as an agonist in cocaine discrimination and similar efficacy as a reinforcer and discriminative stimulus relative to dextroamphetamine. However, 2-fluoromethamphetamine produced an atypically long duration of action when given intravenously to rats, suggesting that its pharmacokinetics may differ from those of other amphetamines.
4-FMA and 2-FMA (Mefedron) are the same drugs but are marketed under different brand names. Contrary to popular belief, 4-FMA and MDPV are not synthetic amphetamines - they assay negative for amphetamine presence in standard toxicology screens! While the salts of these drugs do contain at least some amount of metallic cation, they do not appear to have any hallucinogenic potential (according to our pharmacokinetic analysis). The "4" and "2" designations refer to the number of fluorine molecules attached along the chain of carbon atoms.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics